The Audit® MicroControls™ Linearity FLQ TDM for Abbott systems is intended to simulate human patient samples for use in determining linearity, calibration verification, and the verification of reportable range for the following analytes: Acetominophen, Amikacin, Carbamezepine, Digoxin, Gentamicin, Phenobarbital, Phenytoin, Salicylate, Theophylline, Tobramycin, Valproic Acid, Vancomycin.

Five distinct levels that demonstrate a linear relationship to each other for their respective analytes, reagents and instruments.